 | • レポートコード：MRC2-11QY12531 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肝疾患治療のグローバル市場について調査・分析したレポートです。種類別（肝臓有毒傷害、感染性病原体・寄生虫、免疫障害、腫瘍、遺伝性肝疾患）市場規模、用途別（病院、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肝疾患治療の競争状況、市場シェア ・世界の肝疾患治療市場：種類別市場規模 2015年-2020年（肝臓有毒傷害、感染性病原体・寄生虫、免疫障害、腫瘍、遺伝性肝疾患） ・世界の肝疾患治療市場：種類別市場規模予測 2021年-2026年（肝臓有毒傷害、感染性病原体・寄生虫、免疫障害、腫瘍、遺伝性肝疾患） ・世界の肝疾患治療市場：用途別市場規模 2015年-2020年（病院、専門クリニック） ・世界の肝疾患治療市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック） ・北米の肝疾患治療市場分析：米国、カナダ ・ヨーロッパの肝疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肝疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肝疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肝疾患治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Achillion Pharmaceuticals、Actavis、Alkermes、Antipodean Pharmaceuticals、Bayer Healthcare Pharmaceuticals、Biotest、Bristol-Myers Squibb、Conatus Pharmaceuticals、Eli Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis.
Viral hepatitis is one of the major liver diseases affecting a large number of people across the globe.
Market Analysis and Insights: Global Liver Disease Treatment Market
The global Liver Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Liver Disease Treatment Scope and Market Size
Liver Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liver Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Achillion Pharmaceuticals
Actavis
Alkermes
Antipodean Pharmaceuticals
Bayer Healthcare Pharmaceuticals
Biotest
Bristol-Myers Squibb
Conatus Pharmaceuticals
Eli Lilly
Market segment by Type, the product can be split into
Toxic Injury To The Liver
Infectious Agents And Parasites
Immune Disorders
Tumors
Inherited Liver Diseases
Market segment by Application, split into
Hospitals
Specialty Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Liver Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Liver Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Toxic Injury To The Liver
1.4.3 Infectious Agents And Parasites
1.4.4 Immune Disorders
1.4.5 Tumors
1.4.6 Inherited Liver Diseases
1.5 Market by Application
1.5.1 Global Liver Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Liver Disease Treatment Market Perspective (2015-2026)
2.2 Global Liver Disease Treatment Growth Trends by Regions
2.2.1 Liver Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Liver Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Liver Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Liver Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Liver Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Liver Disease Treatment Players by Market Size
3.1.1 Global Top Liver Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Liver Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Liver Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Liver Disease Treatment Market Concentration Ratio
3.2.1 Global Liver Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Liver Disease Treatment Revenue in 2019
3.3 Liver Disease Treatment Key Players Head office and Area Served
3.4 Key Players Liver Disease Treatment Product Solution and Service
3.5 Date of Enter into Liver Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Liver Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Liver Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Liver Disease Treatment Market Size by Application (2015-2020)
5.2 Global Liver Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Liver Disease Treatment Market Size (2015-2020)
6.2 Liver Disease Treatment Key Players in North America (2019-2020)
6.3 North America Liver Disease Treatment Market Size by Type (2015-2020)
6.4 North America Liver Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Liver Disease Treatment Market Size (2015-2020)
7.2 Liver Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Liver Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Liver Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Liver Disease Treatment Market Size (2015-2020)
8.2 Liver Disease Treatment Key Players in China (2019-2020)
8.3 China Liver Disease Treatment Market Size by Type (2015-2020)
8.4 China Liver Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Liver Disease Treatment Market Size (2015-2020)
9.2 Liver Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Liver Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Liver Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Liver Disease Treatment Market Size (2015-2020)
10.2 Liver Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Liver Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Liver Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Liver Disease Treatment Market Size (2015-2020)
11.2 Liver Disease Treatment Key Players in India (2019-2020)
11.3 India Liver Disease Treatment Market Size by Type (2015-2020)
11.4 India Liver Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Liver Disease Treatment Market Size (2015-2020)
12.2 Liver Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Liver Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Liver Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Liver Disease Treatment Introduction
13.1.4 Abbott Laboratories Revenue in Liver Disease Treatment Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Achillion Pharmaceuticals
13.2.1 Achillion Pharmaceuticals Company Details
13.2.2 Achillion Pharmaceuticals Business Overview
13.2.3 Achillion Pharmaceuticals Liver Disease Treatment Introduction
13.2.4 Achillion Pharmaceuticals Revenue in Liver Disease Treatment Business (2015-2020)
13.2.5 Achillion Pharmaceuticals Recent Development
13.3 Actavis
13.3.1 Actavis Company Details
13.3.2 Actavis Business Overview
13.3.3 Actavis Liver Disease Treatment Introduction
13.3.4 Actavis Revenue in Liver Disease Treatment Business (2015-2020)
13.3.5 Actavis Recent Development
13.4 Alkermes
13.4.1 Alkermes Company Details
13.4.2 Alkermes Business Overview
13.4.3 Alkermes Liver Disease Treatment Introduction
13.4.4 Alkermes Revenue in Liver Disease Treatment Business (2015-2020)
13.4.5 Alkermes Recent Development
13.5 Antipodean Pharmaceuticals
13.5.1 Antipodean Pharmaceuticals Company Details
13.5.2 Antipodean Pharmaceuticals Business Overview
13.5.3 Antipodean Pharmaceuticals Liver Disease Treatment Introduction
13.5.4 Antipodean Pharmaceuticals Revenue in Liver Disease Treatment Business (2015-2020)
13.5.5 Antipodean Pharmaceuticals Recent Development
13.6 Bayer Healthcare Pharmaceuticals
13.6.1 Bayer Healthcare Pharmaceuticals Company Details
13.6.2 Bayer Healthcare Pharmaceuticals Business Overview
13.6.3 Bayer Healthcare Pharmaceuticals Liver Disease Treatment Introduction
13.6.4 Bayer Healthcare Pharmaceuticals Revenue in Liver Disease Treatment Business (2015-2020)
13.6.5 Bayer Healthcare Pharmaceuticals Recent Development
13.7 Biotest
13.7.1 Biotest Company Details
13.7.2 Biotest Business Overview
13.7.3 Biotest Liver Disease Treatment Introduction
13.7.4 Biotest Revenue in Liver Disease Treatment Business (2015-2020)
13.7.5 Biotest Recent Development
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Details
13.8.2 Bristol-Myers Squibb Business Overview
13.8.3 Bristol-Myers Squibb Liver Disease Treatment Introduction
13.8.4 Bristol-Myers Squibb Revenue in Liver Disease Treatment Business (2015-2020)
13.8.5 Bristol-Myers Squibb Recent Development
13.9 Conatus Pharmaceuticals
13.9.1 Conatus Pharmaceuticals Company Details
13.9.2 Conatus Pharmaceuticals Business Overview
13.9.3 Conatus Pharmaceuticals Liver Disease Treatment Introduction
13.9.4 Conatus Pharmaceuticals Revenue in Liver Disease Treatment Business (2015-2020)
13.9.5 Conatus Pharmaceuticals Recent Development
13.10 Eli Lilly
13.10.1 Eli Lilly Company Details
13.10.2 Eli Lilly Business Overview
13.10.3 Eli Lilly Liver Disease Treatment Introduction
13.10.4 Eli Lilly Revenue in Liver Disease Treatment Business (2015-2020)
13.10.5 Eli Lilly Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Liver Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Liver Disease Treatment Revenue
Table 3. Ranking of Global Top Liver Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Liver Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Toxic Injury To The Liver
Table 6. Key Players of Infectious Agents And Parasites
Table 7. Key Players of Immune Disorders
Table 8. Key Players of Tumors
Table 9. Key Players of Inherited Liver Diseases
Table 10. Global Liver Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Liver Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Liver Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Liver Disease Treatment Market Share by Regions (2015-2020)
Table 14. Global Liver Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Liver Disease Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Liver Disease Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Liver Disease Treatment Players
Table 21. Global Liver Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Liver Disease Treatment Market Share by Players (2015-2020)
Table 23. Global Top Liver Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Disease Treatment as of 2019)
Table 24. Global Liver Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Liver Disease Treatment Product Solution and Service
Table 27. Date of Enter into Liver Disease Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Liver Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Liver Disease Treatment Market Size Share by Type (2015-2020)
Table 31. Global Liver Disease Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Liver Disease Treatment Market Size Share by Application (2015-2020)
Table 33. Global Liver Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Liver Disease Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Liver Disease Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Liver Disease Treatment Market Share (2019-2020)
Table 37. North America Liver Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Liver Disease Treatment Market Share by Type (2015-2020)
Table 39. North America Liver Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Liver Disease Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Liver Disease Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Liver Disease Treatment Market Share (2019-2020)
Table 43. Europe Liver Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Liver Disease Treatment Market Share by Type (2015-2020)
Table 45. Europe Liver Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Liver Disease Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Liver Disease Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Liver Disease Treatment Market Share (2019-2020)
Table 49. China Liver Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Liver Disease Treatment Market Share by Type (2015-2020)
Table 51. China Liver Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Liver Disease Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Liver Disease Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Liver Disease Treatment Market Share (2019-2020)
Table 55. Japan Liver Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Liver Disease Treatment Market Share by Type (2015-2020)
Table 57. Japan Liver Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Liver Disease Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Liver Disease Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Liver Disease Treatment Market Share (2019-2020)
Table 61. Southeast Asia Liver Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Liver Disease Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Liver Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Liver Disease Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Liver Disease Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Liver Disease Treatment Market Share (2019-2020)
Table 67. India Liver Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Liver Disease Treatment Market Share by Type (2015-2020)
Table 69. India Liver Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Liver Disease Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Liver Disease Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Liver Disease Treatment Market Share (2019-2020)
Table 73. Central & South America Liver Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Liver Disease Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Liver Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Liver Disease Treatment Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. Achillion Pharmaceuticals Company Details
Table 83. Achillion Pharmaceuticals Business Overview
Table 84. Achillion Pharmaceuticals Product
Table 85. Achillion Pharmaceuticals Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 86. Achillion Pharmaceuticals Recent Development
Table 87. Actavis Company Details
Table 88. Actavis Business Overview
Table 89. Actavis Product
Table 90. Actavis Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 91. Actavis Recent Development
Table 92. Alkermes Company Details
Table 93. Alkermes Business Overview
Table 94. Alkermes Product
Table 95. Alkermes Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 96. Alkermes Recent Development
Table 97. Antipodean Pharmaceuticals Company Details
Table 98. Antipodean Pharmaceuticals Business Overview
Table 99. Antipodean Pharmaceuticals Product
Table 100. Antipodean Pharmaceuticals Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 101. Antipodean Pharmaceuticals Recent Development
Table 102. Bayer Healthcare Pharmaceuticals Company Details
Table 103. Bayer Healthcare Pharmaceuticals Business Overview
Table 104. Bayer Healthcare Pharmaceuticals Product
Table 105. Bayer Healthcare Pharmaceuticals Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 106. Bayer Healthcare Pharmaceuticals Recent Development
Table 107. Biotest Company Details
Table 108. Biotest Business Overview
Table 109. Biotest Product
Table 110. Biotest Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 111. Biotest Recent Development
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Product
Table 114. Bristol-Myers Squibb Company Details
Table 115. Bristol-Myers Squibb Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Conatus Pharmaceuticals Company Details
Table 118. Conatus Pharmaceuticals Business Overview
Table 119. Conatus Pharmaceuticals Product
Table 120. Conatus Pharmaceuticals Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 121. Conatus Pharmaceuticals Recent Development
Table 122. Eli Lilly Company Details
Table 123. Eli Lilly Business Overview
Table 124. Eli Lilly Product
Table 125. Eli Lilly Revenue in Liver Disease Treatment Business (2015-2020) (Million US$)
Table 126. Eli Lilly Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Toxic Injury To The Liver Features
Figure 3. Infectious Agents And Parasites Features
Figure 4. Immune Disorders Features
Figure 5. Tumors Features
Figure 6. Inherited Liver Diseases Features
Figure 7. Global Liver Disease Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Liver Disease Treatment Report Years Considered
Figure 11. Global Liver Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Liver Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Liver Disease Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Liver Disease Treatment Market Share by Players in 2019
Figure 16. Global Top Liver Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Disease Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Liver Disease Treatment Revenue in 2019
Figure 18. North America Liver Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Liver Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Liver Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Liver Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Liver Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Liver Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Liver Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
非アルコール性脂肪性肝疾患治療の世界市場（～2026年） Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…- 非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …
- 脂肪肝治療の世界市場（～2026年） Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells. The major risks associated with fatty liver disease are alcoholic cirrhosis, cardiovascular disorder, metabolic syndrome and biliary cirrhosis among others. Market Analysis and Insi…
- 感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…
- 肝生検の世界市場（～2026年） Liver biopsy is the biopsy (removal of a small sample of tissue) from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment. Liver biopsies may be taken percutaneously (via a needle thro…